Co-Occurring Infections in Cancer Patients Treated with Checkpoint Inhibitors Significantly Increase the Risk of Immune-Related Adverse Events
Article in Cancers (August 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Hepatic injury and hepatic failure adverse events in 3,4-methylenedioxymethamphetamine users reported to the FDA Adverse Event Reporting System
Article in Frontiers in Psychiatry (June 2024)
3,4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy: what the pharmacist needs to know
Article in Journal of Pharmacy Practice and Research (May 2024)